Adrastia Biotechnology Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Adrastia Biotechnology General Information

Description

Developer of a non-invasive system designed to detect breast cancer using the patient's urine. The company's device develops an assay for breast cancer that can be detected in urine and results in a less expensive, sensitive detection system, enabling physicians to monitor these women for activation of breast cancer genes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 7862 Barrow Street
  • Sutter, CA 95982
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 7862 Barrow Street
  • Sutter, CA 95982
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adrastia Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 03-Oct-2026 Completed Out of Business
4. Secondary Transaction - Private 15-Feb-2024 Completed Startup
3. Accelerator/Incubator 10-May-2016 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. Grant 01-Jan-2014 $5K Completed Startup
To view Adrastia Biotechnology’s complete valuation and funding history, request access »

Adrastia Biotechnology Patents

Adrastia Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3183366-A1 Systems and methods of detecting solid tumor cancer Active 18-Aug-2014
EP-3183366-A4 Systems and methods of detecting solid tumor cancer Active 18-Aug-2014
EP-3183366-B1 Systems and methods of detecting solid tumor cancer Active 18-Aug-2014
US-20170233824-A1 Systems and methods of detecting solid tumor cancer Inactive 18-Aug-2014
WO-2016028805-A1 Systems and methods of detecting solid tumor cancer Inactive 18-Aug-2014 C12Q1/6886
To view Adrastia Biotechnology’s complete patent history, request access »

Adrastia Biotechnology FAQs

  • When was Adrastia Biotechnology founded?

    Adrastia Biotechnology was founded in 2013.

  • Where is Adrastia Biotechnology headquartered?

    Adrastia Biotechnology is headquartered in Sutter, CA.

  • What industry is Adrastia Biotechnology in?

    Adrastia Biotechnology’s primary industry is Other Devices and Supplies.

  • Is Adrastia Biotechnology a private or public company?

    Adrastia Biotechnology is a Private company.

  • What is Adrastia Biotechnology’s current revenue?

    The current revenue for Adrastia Biotechnology is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process